Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports the formation of targeted therapies by enabling selective binding to enzyme active sites. Commonly employed in medicinal chemistry for constructing heterocyclic frameworks found in bioactive molecules. Also utilized in research settings to design and optimize new drug candidates, especially those involving signal transduction pathways.